BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gerke O, Ehlers K, Motschall E, Høilund-Carlsen PF, Vach W. PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues. Mol Imaging Biol 2020;22:33-46. [PMID: 31016638 DOI: 10.1007/s11307-019-01351-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hildebrandt MG, Lauridsen JF, Vogsen M, Holm J, Vilstrup MH, Braad PE, Gerke O, Thomassen M, Ewertz M, Høilund-Carlsen PF; Centre for Personalized Response Monitoring in Oncology (PREMIO). FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond. Cancers (Basel) 2019;11:E1190. [PMID: 31443324 DOI: 10.3390/cancers11081190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Filippi L, Sardella B, Schillaci O, Bagni O. Mycobacterial Lymphadenitis in a Human Immunodeficiency Virus-Infected Patient: Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring the Response to Treatment. Indian J Nucl Med 2019;34:329-31. [PMID: 31579359 DOI: 10.4103/ijnm.IJNM_125_19] [Reference Citation Analysis]
3 Ponsiglione A, Ascione R, Nappi C, Imbriaco M, Klain M, Cuocolo R, Cuocolo A, Petretta M. Cardiac hybrid imaging: novel tracers for novel targets. J Geriatr Cardiol 2021;18:748-58. [PMID: 34659381 DOI: 10.11909/j.issn.1671-5411.2021.09.006] [Reference Citation Analysis]
4 Høilund-Carlsen PF, Piri R, Constantinescu C, Iversen KK, Werner TJ, Sturek M, Alavi A, Gerke O. Atherosclerosis Imaging with 18F-Sodium Fluoride PET. Diagnostics (Basel) 2020;10:E852. [PMID: 33092250 DOI: 10.3390/diagnostics10100852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Høilund-Carlsen PF, Edenbrandt L, Alavi A. Global disease score (GDS) is the name of the game! Eur J Nucl Med Mol Imaging 2019;46:1768-72. [PMID: 31183636 DOI: 10.1007/s00259-019-04383-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
6 Liapis V, Tieu W, Wittwer NL, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH. Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models. Mol Imaging Biol 2021. [PMID: 34231102 DOI: 10.1007/s11307-021-01620-1] [Reference Citation Analysis]